SignalPath raises $18m ahead of trial management platform expansion

By Vassia Barba

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags SignalPath Data management Clinical data management Clinical trial data

SignalPath announced the closing of its Series B funding round to support the expansion of its software platform, which facilitates clinical trials management.

SignalPath, a North Carolina, US-based software developer, has raised $18m (€16.18m) from existing investors, bringing its total capital to $35m (€31.46m), in order to support the expansion of its suite of tools available for clinical trial sites.

The company holds a software platform with tools allowing clinical data storage and management, with an aim to “reduce complexity, drive efficiency, improve quality, and increase transparency across the research ecosystem,”​ according to Brad Hirsch, the company’s CEO.

To date, approximately 250 clinical sites have access to the platform, with the volume of the network ultimately allowing the company to move on to developing insights about clinical research, a project which was previously ‘impossible to conduct’, Hirsch stated.

The funding is expected to support the development of software tools providing these insights, as well as to enable the growth of the company’s research teams.

In 2018, the company announced the launch of a research consortium, with the aim of bringing together technology companies, sponsors and researchers.

The company’s CEO told us then​ that the company aims to have integrated the use of real world data in clinical study design and management by 2020.

Related news

Show more

Related products

show more

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Validate clinical study data with Formedix CORE

Validate clinical study data with Formedix CORE

Content provided by Formedix | 19-Jun-2023 | White Paper

In April 2023 at the CDISC Europe Interchange, we launched Formedix CORE, the first free-to-use, downloadable application encompassing the CDISC Open Rules...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Content provided by Formedix | 17-Apr-2023 | White Paper

Companies often have to conduct multiple clinical trials at the same time, which means they've got to be efficient, and compliant with industry regulations....

Related suppliers

Follow us


View more